Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1988 | 1 |
1991 | 1 |
1992 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
ICRF-187 permits longer treatment with doxorubicin in women with breast cancer.
J Clin Oncol. 1992 Jan;10(1):117-27. doi: 10.1200/JCO.1992.10.1.117.
J Clin Oncol. 1992.
PMID: 1727913
Clinical Trial.
ICRF-187 (ADR-529) cardioprotection against anthracycline-induced cardiotoxicity: clinical and preclinical studies.
Green MD, Alderton P, Sobol MM, Gross J, Muggia FM, Speyer JL.
Green MD, et al.
Cancer Treat Res. 1991;58:101-17. doi: 10.1007/978-1-4615-3876-9_6.
Cancer Treat Res. 1991.
PMID: 1683780
Review.
No abstract available.
Item in Clipboard
Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer.
Speyer JL, Green MD, Kramer E, Rey M, Sanger J, Ward C, Dubin N, Ferrans V, Stecy P, Zeleniuch-Jacquotte A, et al.
Speyer JL, et al.
N Engl J Med. 1988 Sep 22;319(12):745-52. doi: 10.1056/NEJM198809223191203.
N Engl J Med. 1988.
PMID: 3137469
Clinical Trial.
Item in Clipboard
Cite
Cite